Lagerstandorte

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Vorbehaltlich Verfügbarkeit

Dokumentation

MSDS herunterladen

Beispiel-COA herunterladen

Enthält: HPLC, MASS/LC-MS, 1H-NMR, FT-IR, Gehalt, Structure Elucidation Report (SER) sowie zusätzliche analytische Daten je nach Produkt.

128196-01-0Escitalopram Working Standard (Secondary Reference Standard)

● Under Development

Katalog-Nr.::	VE0027386
CAS-Nr.::	128196-01-0
Summenformel::	C20H21FN2O
Molare Masse::	324.39 g/mol

Wie können wir helfen?

Zur RFQ-Liste hinzufügen

Zusätzliche Informationen zu CAS 128196-01-0

Parent drug

Escitalopram

IUPAC-Name

(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile

SMILES

CN(C)CCC[C@@]1(C2=CC=C(F)C=C2)OCC3=C1C=CC(C#N)=C3

InChI

InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1

Beschreibung

Escitalopram Working Standard (Secondary Reference Standard), CAS 128196-01-0, is supplied as a rigorously characterized secondary reference material intended solely for research and analytical method development and is not certified for use as a primary reference standard for GMP QC batch release or regulatory stability studies. Each lot is accompanied by a certificate of analysis detailing purity by HPLC, impurity profile, assigned assay value with uncertainty, homogeneity and stability data, and storage and handling instructions. Manufactured under controlled conditions with documented traceability, the material supports method validation and instrument calibration workflows requiring traceable, lot-specific documentation.